Records containing: Keratosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-09Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
-
CLINICAL_TRIALS study record update · 2024-10-17A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BF-200 ALA (Ameluz®) in the Expanded Field-directed Treatment of Actinic Keratosis on the Face and Scalp With Photodynamic Therapy (PDT)
-
CLINICAL_TRIALS study record update · 2024-03-07Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
-
CLINICAL_TRIALS study record update · 2024-02-28Use of a Tissue Autofluorescence Detection System for Identification of Oral Mucosal Lesions
-
CLINICAL_TRIALS study record update · 2021-04-28A Longitudinal Quantitative Assessment of the Effectiveness of Metatarsal Pads on Plantar Pressures
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-04-04Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection
-
CLINICAL_TRIALS study record update · 2019-03-08A Pilot Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
-
CLINICAL_TRIALS study record update · 2016-08-01Efficacy of Tobacco Cessation for Improving Oral Diseases - Multicenter Prospective Trial
-
CLINICAL_TRIALS study record update · 2015-05-27The Effect of Efudex (5-fluorouracil) Treatment on Photoaged Skin
-
CLINICAL_TRIALS study record update · 2015-03-25An Open-label, Dose Escalation, Cohort Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel When Applied on Day 1 and Day 2 to Actinic Keratoses on the Shoulders, Chest, Back or Arms Followed by a Post-Treatment Follow-up Period Lasting at Four Weeks
-
CLINICAL_TRIALS study record update · 2008-11-25Open-Label Safety and Pharmacokinetic Study of AldaraTM (Imiquimod) Cream, 5% for One, Two, or Three Treatment Cycles to Surface Areas Greater Than 25 cm2 With Actinic Keratosis
-
CLINICAL_TRIALS study record update · 2008-04-24A Randomized, Parallel-Group, Vehicle-Controlled, Double-Blind Study of Topical Imiquimod 5% Cream Used as an Adjunct to Cryotherapy in the Management of Actinic Keratoses, With a Long-Term (1 Year) Follow-Up
-
CLINICAL_TRIALS study record update · 2007-02-19Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Upper Extremities
-
CLINICAL_TRIALS study record update · 2007-02-19A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1473-IMIQ Study